The gut microbiome is a vital and important part of human health that touches so many aspects of our daily lives, yet it works in very unpredictable ways.
For example, consider how certain drugs interact with the human gut. Sometimes, they do work but not so well at other times, as we learned about statin drugs.
“For example, certain drugs work fine when given intravenously and go directly to the [blood] circulation, but when they are taken orally and pass through the gut, they don’t work,” says senior study author Dr. Hariom Yadav, a researcher at the Wake Forest School of Medicine.
As we’ve seen previously, metformin works well with the gut, although some patients who take it tend to experience more side effects (nausea, diarrhea and flatulence).
Based on their review of studies, Wake Forest researchers determined the metabolic capacity of a patient’s microbiome may influence how various drugs aimed at treating type 2 diabetes are absorbed and function in effective, inactive or even toxic ways.
“We believe that differences in an individual’s microbiome help explain why drugs will show a 90 or 50 percent optimum efficacy, but never 100 percent,” Dr. Yadav said.
Now, Wake Forest researchers are taking the next important gut-friendly step by testing prebiotics, a natural component of non-digestible plant fiber that feeds the good bacteria living in your gut, and probiotics that may help diabetes drugs work more effectively.
Could a multi-species probiotic containing 10 kinds of beneficial bacteria plus a handy prebiotic (FOS) like EndoMune Advanced Probiotic make gut-friendly difference in the way patients take their drugs?
The evidence is growing!